THERAPEUTIC TARGETS FOR ACUTE MYELOID LEUKEMIA (AML)

被引:0
作者
Sorbera, L. A. [1 ]
Verges, C. [1 ]
Dulsat, C. [1 ]
机构
[1] Prous Sci, Barcelona 08025, Spain
关键词
NF-KAPPA-B; DEHYDROGENASE INHIBITORS; MYELODYSPLASTIC SYNDROME; GROWTH-INHIBITION; CANCER; KINASE; CELL; GENE; MUTATIONS; RECEPTOR;
D O I
10.1358/dof.2009.034.01.1328631
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute myeloid leukemia (AML) is a cancer of the myeloid line of white blood cells and is characterized by the hyperproliferation of abnormal cells, which collect in the bone marrow and disrupt normal blood cell production Replacement of normal bone marrow with leukemic cells causes a decrease in the levels of red blood cells, platelets and normal white blood cells Symptoms include fatigue, shortness of breath, a heightened risk of bruising and bleeding, and on elevated risk of infection Risk factors for AML have been identified, but the specific cause is still unknown Treatment generally involves chemotherapy and, in some cases, hematopoietic stem cell transplantation Treatment strategies for AML ore currently focusing on the discovery of new drug targets and prognostic indicators, as well as the detection of residual disease subsequent to treatment This article provides insight into the search for new and Improved treatment options by detailing the putative targets for drugs currently under active investigation for AML
引用
收藏
页码:67 / 77
页数:11
相关论文
共 66 条
  • [61] Tumor necrosis factor signaling
    Wajant, H
    Pfizenmaier, K
    Scheurich, P
    [J]. CELL DEATH AND DIFFERENTIATION, 2003, 10 (01) : 45 - 65
  • [62] Tubulin-associated Proteins: Aurora and Polo-like Kinases as Therapeutic Targets in Cancer
    Warner, Steven L.
    Stephens, Bret J.
    Von Hoff, Daniel D.
    [J]. CURRENT ONCOLOGY REPORTS, 2008, 10 (02) : 122 - 129
  • [63] The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemia
    Wegiel, B.
    Ekberg, J.
    Talasila, K. M.
    Jalili, S.
    Persson, J. L.
    [J]. LEUKEMIA, 2009, 23 (02) : 251 - 261
  • [64] Xie JP, 1997, EXP HEMATOL, V25, P1111
  • [65] Expanding circle of inhibition:: Small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents
    Zeitlin, Benjamin D.
    Zeitlin, Isaac J.
    Nor, Jacques E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) : 4180 - 4188
  • [66] Translocations of the RARα gene in acute promyelocytic leukemia
    Zelent, A
    Guidez, F
    Melnick, A
    Waxman, S
    Licht, JD
    [J]. ONCOGENE, 2001, 20 (49) : 7186 - 7203